Perfusion Systems Market Report 2026

Perfusion Systems Market Overview

• Perfusion Systems market size has reached to $1.45 billion in 2025 • Expected to grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Surge In Organ Transplants Fuels Growth In The Perfusion Systems Market • Market Trend: The Impact Of Persorb Adsorber And Perlife Organ Perfusion System On Perfusion Systems Market • North America was the largest region in 2025.

What Is Covered Under Perfusion Systems Market?

Perfusion systems refer to medical devices used to support the circulation and oxygenation of a patient's blood during surgical procedures that require temporary interruption of the heart's normal function. It is commonly used in cardiac surgery, organ transplants, and other procedures that require temporary organ function replacement. The main product types of perfusion systems are cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and others. A cardiopulmonary perfusion system is a device used during cardiac surgeries to temporarily replace the function of the heart and lungs. The various types of organs include the heart, lung, kidney, liver, and other types of organs. The various techniques include hypothermic and normothermic. These are used by various end-users such as hospitals, clinics, ambulatory surgical centers, and others.

What Is The Perfusion Systems Market Growth Forecast?

The perfusion systems market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing investments in advanced surgical care facilities, rising demand for portable and modular perfusion systems, expansion of organ preservation applications, growing focus on patient safety and outcome optimization, continued innovation in perfusion device automation. Major trends in the forecast period include increasing adoption of advanced ecmo platforms, rising use of normothermic perfusion techniques, growing integration of perfusion monitoring systems, expansion of portable perfusion solutions, enhanced focus on organ preservation technologies.

Global Perfusion Systems Market Segmentation

1) By Product: Cardiopulmonary Perfusion System, Extracorporeal membrane oxygenation (ECMO), Isolated Organ Perfusion Systems 2) By Type Of Organ: Heart, Lung, Kidney, Liver, Other Type Of Organs 3) By Technique: Hypothermic, Normothermic 4) By End-User: Hospital, Clinic Subsegments: 1) By Cardiopulmonary Perfusion System: Heart-Lung Machines, Blood Pumps, Oxygenators 2) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Arterial (VA) ECMO Systems, Veno-Venous (VV) ECMO Systems, Portable ECMO Systems 3) By Isolated Organ Perfusion Systems: Liver Perfusion Systems, Kidney Perfusion Systems, Heart Perfusion Systems

What Is The Driver Of The Perfusion Systems Market?

The rising number of organ transplants is expected to propel the growth of the perfusion systems market going forward. Organ transplants refer to a surgical procedure where a diseased or damaged organ is removed from a donor and transplanted into a recipient who needs it due to organ failure or disease. Perfusion systems are used to preserve and transport organs during the transplantation process and play a critical role in maintaining the viability of the donated organs. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based federally authorized system for fair organ transplant allocation, there were 46,632 organ transplants performed in the United States in 2023, an 8.7% increase over 2022. Therefore, the rise in the number of organ transplants is driving the demand for the perfusion systems industry.

Key Players In The Global Perfusion Systems Market

Major companies operating in the perfusion systems market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB, XENIOS AG, Sorin Group, Organ Assist Products B.V., Organ Recovery Systems Inc., TransMedics Inc., Paragonix Technologies Inc., Bridge to Life Europe Ltd., OrganOx Limited, Preservation Solutions Inc., Repligen Corporation, Spectrum Laboratories Inc., Harvard Bioscience Inc., ALA Scientific Instruments Inc., Bioptechs Inc., Cytiva

Global Perfusion Systems Market Trends and Insights

Major companies operating in the perfusion systems market are focused on developing innovative products, such as, Essenz patient monitor, to enhance clinical efficiency and patient care during cardiopulmonary bypass procedures. This innovative monitoring system features a centralized display that continuously shows patient parameters, allowing for tailored patient management strategies. For instance, in February 2023, LivaNova, a UK-based provider of neuromodulation devices and cardiopulmonary products, launched the Essenz perfusion system in Europe. The Essenz system is a compact, modular, portable cardiopulmonary bypass (CPB) system designed for cardiac surgeries. The system's modular design allows it to be customized to meet the specific needs of individual patients and surgical procedures. The compact and portable nature of the system also enables easy transport and setup in various clinical settings.

What Are Latest Mergers And Acquisitions In The Perfusion Systems Market?

In September 2024, Getinge, a Sweden-based provider of hospital and life-science equipment and solutions, acquired Paragonix Technologies for $477 million. Through this acquisition, Getinge aims to expand its presence in the rapidly growing organ preservation and transport sector by integrating Paragonix’s advanced organ transport and perfusion technologies with its global commercial network. Paragonix Technologies is a US-based developer of perfusion systems used for preserving and transporting donor organs.

Regional Outlook

North America was the largest region in the perfusion systems market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Perfusion Systems Market?

The perfusion systems market consists of revenues earned by entities by providing organ transplantation services, blood management services, cell isolation care, and cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.